A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(9 sites)

United States

Florida Cancer Specialists - Fort Myers, Fort Myers, Florida

University of Texas MD Anderson Cancer Center, Houston, Texas

Australia

Scientia Clinical Research Ltd, Randwick, New South Wales

France

Centre Leon Berard, Lyon

Germany

Evangelische Lungenklinik, Berlin

Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

Japan

National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido

Switzerland

Universitaetsspital Basel, Basel

Taiwan

Taichung Veterans General Hospital, Taichung